PaxMedica Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	11.71	12.23	8.82	4.97	4.63	0.11
Research & Development	4.09	3.91	1.79	2.22	0.94	0.48
Other Operating Expenses	-2.34	0	-5.51	0.17	-0.05	0
Operating Expenses	15.8	16.15	10.6	7.2	5.57	0.6
Operating Income	-15.8	-16.15	-10.6	-7.2	-5.57	-0.6
Interest Expense	-9.17	0.01	0.01	2.81	0.61	0
Other Expense / Income	11.32	2.14	4.19	0.23	1.65	-
Pretax Income	-18.15	-18.29	-14.8	-10.23	-7.83	-0.6
Income Tax	0.2	0	4.19	2.81	0.66	0
Net Income	-18.15	-18.29	-18.99	-13.03	-8.49	-0.6
Shares Outstanding (Basic)	0	2	1	1	1	10
Shares Outstanding (Diluted)	0	2	1	1	1	10
Shares Change	-41.30%	134.87%	2.17%	-	-93.08%	-
EPS (Basic)	-18.50	-11.00	-26.83	-18.81	-12.25	-0.06
EPS (Diluted)	-18.50	-11.00	-26.83	-18.81	-12.25	-0.06
Free Cash Flow	-10.85	-10.77	-6.07	-5.51	-2.35	-0.42
Free Cash Flow Per Share	-24.87	-6.48	-8.58	-7.96	-3.39	-0.04
EBITDA	-16.25	-16.15	-16.51	-7.02	-5.62	-0.6
EBIT	-27.12	-18.28	-14.8	-7.42	-7.22	-0.6

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.